FDA will OK updated COVID vaccines for some
Digest more
U.S. health officials knew about the risks of myocarditis from COVID-19 vaccines but downplayed the concern and delayed informing the public about the risks of taking the jab — that is according to a new Senate report released by Sen.
Top health officials were aware of and actively took steps to “delay warning the public” for months in 2021 about the potential risks of patients suffering from heart-related
Help Register Login Login Hi, %{firstName}% Hi, %{firstName}% Games Car rental The U.S. Food and Drug Administration (FDA) has officially approved a COVID-19 vaccine from Novavax for adults 65 and older and for individuals ages 12 to 64 who have an underlying health condition that puts them at higher risk for serious illness from a coronavirus infection.
Following discharge for COVID-19 hospitalization, county-level social deprivation does not affect long-term cardiovascular risk.
Cardiovascular issues are common, and now some experts term severe COVID an independent coronary artery disease risk factor needing aggressive management.